Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.31 CAD
Change Today -0.015 / -4.62%
Volume 500.0
As of 4:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James R. Howard-Tripp

Executive Chairman, Member of Compensation & Human Resources Committee and Member of Strategy Committee, GeneNews Limited
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 2 different industries.

See Board Relationships
--C$438,216
As of Fiscal Year 2014

Background*

Mr. James R. Howard-Tripp has been an Executive Chairman of GeneNews Limited (also known as ChondroGene Ltd.) since July 2013. Mr. Howard-Tripp served as the President and Chief Executive Officer of Labopharm Inc. from July 2000 to March 2011. He served as the Chairman, Chief Executive Officer and President of Labopharm Europe Ltd. He initially joining Labopharm Inc. as Executive Vice President in March, 2000. From 1996, he held a number of positions with Allelix Biopharmaceuticals ...

Read Full Background

Corporate Headquarters*

445 Apple Creek Boulevard
Markham, Ontario L3R 9X7

Canada

Phone: 905-209-2030
Fax: 905-209-2031

Board Members Memberships*

2002-Present
Executive Chairman, Member of Compensation & Human Resources Committee and Member of Strategy Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

All Other CompensationC$216,570
Total Value of OptionsC$897,750
Total Number of Options854,167

Total Compensation*

Total Annual Cash CompensationC$216,570
Other Long Term CompensationC$216,570
Total Calculated CompensationC$438,216
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEN:CN C$0.31 CAD -0.015

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENENEWS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.